Product Images Glyburide And Metformin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Glyburide And Metformin Hydrochloride NDC 68382-654 by Zydus Pharmaceuticals (usa) Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 4ec3072f 2ab6 47ad abf9 2aa7e5e9c112 01
Image - 4ec3072f 2ab6 47ad abf9 2aa7e5e9c112 02
This is a partial text and it appears to be a list of chemical compounds with abbreviations. The text includes the names "Metformin Hydrochloride". Based on this limited information, the text might be related to a scientific or pharmaceutical context.*
figure - 4ec3072f 2ab6 47ad abf9 2aa7e5e9c112 03
This is a description of a medication called Glyburide and Metformin Hydrochloride tablets, USP. Each coated tablet contains 125mg of Glyburide and 250mg of Metformin Hydrochloride. The pharmacist is instructed to disperse the patient information provided separately to each patient. This medication is available by prescription only and comes in a container of 100 tablets. The manufacturer is Cadila Healthcare L. from Badd, India and it is distributed by Zydus Pharmaceuticals USA Inc. from Pennington, New Jersey. The medication should be stored at 20°C to 25°C (68°F to 77°F) and kept out of reach of children. The complete prescribing information can be found in the package insert.*
figure - 4ec3072f 2ab6 47ad abf9 2aa7e5e9c112 04
This is a description of medication called Glyburide and Metformin Hydrochloride Tablets. Each tablet contains 2.5 mg of Glyburide and 500 mg of Metformin Hydrochloride. The usual dosage is stated to be described in the package insert for complete prescribing information. The medication must be stored at 20-25°C under USP Controlled Room Temperature and dispensed in a tight container. The patient information is provided separately and should be supplied to each patient. The medication is manufactured in India by Cadila Healthcare Ltd and distributed in the USA by Zydus Pharmaceuticals Inc.*
figure - 4ec3072f 2ab6 47ad abf9 2aa7e5e9c112 05
This is a description of a medication named Glyburide and Metformin Hydrochloride Tablets, USP, containing 5 mg/500 mg, manufactured by Cadia Healthcare Ltd in India and distributed by Zydus Pharmaceuticals USA Inc. This medication is prescribed by a doctor and dispensed by a pharmacist, with the usual dosage provided in the package insert or complete prescribing information. The medication should be stored at 20° to 25°C (68" to 77°F) and in a tight container (USP). The package comes with patient information that should be given to each patient.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.